全球医疗保健合约研究外包市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

全球医疗保健合约研究外包市场需求预计将从 2023 年的 557.9 亿美元达到近 1,062.5 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 7.42%。

医疗保健合约研究外包涉及聘请外部组织（称为合约研究组织 (CRO)）代表生物技术公司、製药公司和医疗器材製造商进行临床试验、研究和其他医疗保健相关研究。 CRO 提供专业知识、基础设施和监管合规性，使医疗保健公司能够更有效率、更具成本效益地将新疗法和产品推向市场。将研究活动外包给 CRO 使公司能够强调其核心竞争力，同时利用专业知识和资源来推进医疗创新。

市场动态

药物开发和临床试验的复杂性和成本不断增加，推动了医疗保健合约研究外包市场的发展。製药和生技公司将各种研发活动外包给合约研究组织 (CRO)，以简化流程、降低管理成本并获得专业知识。医疗保健合约研究外包使公司能够利用 CRO 的资源和能力来加速药物发现、开发和监管审批流程。此外，随着公司寻求接触不同的患者群体和监管环境，临床试验的全球化和新兴市场的扩张导致对外包服务的需求不断增长。电子资料采集（EDC）系统和远端监控解决方案等技术进步提高了 CRO 进行临床试验的效率和质量，进一步推动市场成长。此外，对个人化医疗和精准医疗保健的日益关注推动了对 CRO 提供的专业临床研究服务的需求。监管压力和遵守行业标准的需求也支持了外包趋势，因为公司寻求降低风险并确保其产品获得监管部门的批准。此外，COVID-19大流行推动了虚拟临床试验和远端监控解决方案的采用，进一步增加了对医疗保健合约研究外包服务的需求。然而，临床试验的高昂成本和监管障碍可能会阻碍未来几年的市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球医疗保健合约研究外包市场的各个细分市场进行了包容性评估。医疗保健合约研究外包产业的成长和趋势为本研究提供了整体方法。

市场区隔

医疗保健合约研究外包市场报告的这一部分提供了国家和地区层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按类型

• 药物发现（标靶验证、先导化合物辨识、先导化合物优化）
• 临床前
• 临床（一期试验服务、二期试验服务、三期试验服务、四期试验服务）

按服务分类

• 专案管理/临床供应管理
• 资料管理
• 监管/医疗事务
• 医学写作
• 临床监测
• 品质管理/保证
• 生物统计学
• 研究者付款
• 实验室
• 患者和现场招募
• 科技
• 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲医疗保健合约研究外包市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。医疗保健合约研究外包市场的主要参与者包括 ICON Plc、Charles River Laboratories、Syneos Health、IQVIA Inc.、GVK Biosciences Private Limited、Laboratory Corporation Of America Holdings、Parexel International Corporation、Medidata Solutions Inc.、Pharmaron GMBH。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：医疗保健合约研究外包 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 按类型分類的市场吸引力分析
  • 按服务分類的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球医疗保健合约研究外包市场分析：按类型

• 按类型概述
• 按类型分析历史和预测数据
• 药物发现（标靶验证、先导化合物辨识、先导化合物优化）
• 临床前
• 临床（一期试验服务、二期试验服务、三期试验服务、四期试验服务）

第 6 章：全球医疗保健合约研究外包市场分析：按服务分类

• 按服务概览
• 按服务进行历史和预测资料分析
• 专案管理/临床供应管理
• 资料管理
• 监管/医疗事务
• 医学写作
• 临床监测
• 品质管理/保证
• 生物统计学
• 研究者付款
• 实验室
• 患者和现场招募
• 科技
• 其他的

第 7 章：全球医疗保健合约研究外包市场分析：按地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区按国家销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲按国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 8 章：医疗保健合约研究外包公司的竞争格局

• 医疗保健合约研究外包市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 9 章：公司简介

• 顶级公司市占率分析
• 市场集中度
• ICON Plc
• 公司概况
• 公司收入
• 产品
• 最新动态
• Charles River Laboratories
• 公司概况
• 公司收入
• 产品
• 最新动态
• Syneos Health
• 公司概况
• 公司收入
• 产品
• 最新动态
• IQVIA Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• GVK Biosciences Private Limited
• 公司概况
• 公司收入
• 产品
• 最新动态
• Laboratory Corporation Of America Holdings
• 公司概况
• 公司收入
• 产品
• 最新动态
• Parexel International Corporation
• 公司概况
• 公司收入
• 产品
• 最新动态
• Medidata Solutions Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Pharmaron GMBH
• 公司概况
• 公司收入
• 产品
• 最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

The global demand for Healthcare Contract Research Outsourcing Market is presumed to reach the market size of nearly USD 106.25 Billion by 2032 from USD 55.79 Billion in 2023 with a CAGR of 7.42% under the study period 2024-2032.

Healthcare contract research outsourcing involves hiring external organizations, known as contract research organizations (CROs), to conduct clinical trials, research studies, and other healthcare-related research on behalf of biotechnology firms, pharmaceutical companies, and medical device manufacturers. CROs provide expertise, infrastructure, and regulatory compliance, allowing healthcare companies to bring new treatments and products to market more efficiently and cost-effectively. Outsourcing research activities to CROs enables companies to emphasize their core competencies while leveraging specialized knowledge and resources to advance medical innovation.

MARKET DYNAMICS

The increasing complexity and cost of drug development and clinical trials drive the healthcare contract research outsourcing market. Pharmaceutical and biotechnology companies outsource various research and development activities to contract research organizations (CROs) to streamline processes, reduce overhead costs, and access specialized expertise. Healthcare contract research outsourcing enables companies to leverage the resources and capabilities of CROs to accelerate drug discovery, development, and regulatory approval processes. Additionally, the globalization of clinical trials and the expansion of emerging markets contribute to the growing demand for outsourcing services as companies seek to access diverse patient populations and regulatory environments. Technological progress, such as electronic data capture (EDC) systems and remote monitoring solutions, enhance the efficiency and quality of clinical trials carried out by CROs, further driving market growth. Furthermore, the growing focus on personalized medicine & precision healthcare drives the demand for specialized clinical research services offered by CROs. Regulatory pressures and the need for compliance with industry standards also support the outsourcing trend, as companies seek to mitigate risks and ensure regulatory approval for their products. Moreover, the COVID-19 pandemic has propelled the adoption of virtual clinical trials and remote monitoring solutions, further boosting the demand for healthcare contract research outsourcing services. However, the high cost of clinical trials and regulatory hurdles may hinder market growth in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Healthcare Contract Research Outsourcing. The growth and trends of Healthcare Contract Research Outsourcing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Healthcare Contract Research Outsourcing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

• Drug Discovery (Target Validation, Lead Identification, Lead Optimization)
• Pre-clinical
• Clinical (Phase I Trial Services, Phase II Trial Services, Phase III Trial Services, Phase IV Trial Services)

By Services

• Project Management/Clinical Supply Management
• Data Management
• Regulatory/Medical Affairs
• Medical Writing
• Clinical Monitoring
• Quality Management/ Assurance
• Bio-statistics
• Investigator Payments
• Laboratory
• Patient And Site Recruitment
• Technology
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Healthcare Contract Research Outsourcing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Healthcare Contract Research Outsourcing market include ICON Plc, Charles River Laboratories, Syneos Health, IQVIA Inc., GVK Biosciences Private Limited, Laboratory Corporation Of America Holdings, Parexel International Corporation, Medidata Solutions Inc., Pharmaron GMBH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. HEALTHCARE CONTRACT RESEARCH OUTSOURCING - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Type
  • 3.7.2 Market Attractiveness Analysis By Services
  • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET ANALYSIS BY TYPE

• 5.1. Overview By Type
• 5.2. Historical and Forecast Data Analysis By Type
• 5.3. Drug Discovery (Target Validation, Lead Identification, Lead Optimization) Historic and Forecast Sales By Regions
• 5.4. Pre-clinical Historic and Forecast Sales By Regions
• 5.5. Clinical (Phase I Trial Services, Phase II Trial Services, Phase III Trial Services, Phase IV Trial Services) Historic and Forecast Sales By Regions

6. GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET ANALYSIS BY SERVICES

• 6.1. Overview By Services
• 6.2. Historical and Forecast Data Analysis By Services
• 6.3. Project Management/Clinical Supply Management Historic and Forecast Sales By Regions
• 6.4. Data Management Historic and Forecast Sales By Regions
• 6.5. Regulatory/Medical Affairs Historic and Forecast Sales By Regions
• 6.6. Medical Writing Historic and Forecast Sales By Regions
• 6.7. Clinical Monitoring Historic and Forecast Sales By Regions
• 6.8. Quality Management/ Assurance Historic and Forecast Sales By Regions
• 6.9. Bio-statistics Historic and Forecast Sales By Regions
• 6.10. Investigator Payments Historic and Forecast Sales By Regions
• 6.11. Laboratory Historic and Forecast Sales By Regions
• 6.12. Patient And Site Recruitment Historic and Forecast Sales By Regions
• 6.13. Technology Historic and Forecast Sales By Regions
• 6.14. Others Historic and Forecast Sales By Regions

7. GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2 North America By Segment Sales Analysis
  • 7.3.3 North America By Country Sales Analysis
  • 7.3.4 United States Sales Analysis
  • 7.3.5 Canada Sales Analysis
  • 7.3.6 Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2 Europe By Segment Sales Analysis
  • 7.4.3 Europe By Country Sales Analysis
  • 7.4.4 United Kingdom Sales Analysis
  • 7.4.5 France Sales Analysis
  • 7.4.6 Germany Sales Analysis
  • 7.4.7 Italy Sales Analysis
  • 7.4.8 Russia Sales Analysis
  • 7.4.9 Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2 Asia Pacific By Segment Sales Analysis
  • 7.5.3 Asia Pacific By Country Sales Analysis
  • 7.5.4 China Sales Analysis
  • 7.5.5 India Sales Analysis
  • 7.5.6 Japan Sales Analysis
  • 7.5.7 South Korea Sales Analysis
  • 7.5.8 Australia Sales Analysis
  • 7.5.9 South East Asia Sales Analysis
  • 7.5.10 Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2 Latin America By Segment Sales Analysis
  • 7.6.3 Latin America By Country Sales Analysis
  • 7.6.4 Brazil Sales Analysis
  • 7.6.5 Argentina Sales Analysis
  • 7.6.6 Peru Sales Analysis
  • 7.6.7 Chile Sales Analysis
  • 7.6.8 Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2 Middle East & Africa By Segment Sales Analysis
  • 7.7.3 Middle East & Africa By Country Sales Analysis
  • 7.7.4 Saudi Arabia Sales Analysis
  • 7.7.5 UAE Sales Analysis
  • 7.7.6 Israel Sales Analysis
  • 7.7.7 South Africa Sales Analysis
  • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE HEALTHCARE CONTRACT RESEARCH OUTSOURCING COMPANIES

• 8.1. Healthcare Contract Research Outsourcing Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9. COMPANY PROFILES OF HEALTHCARE CONTRACT RESEARCH OUTSOURCING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. ICON Plc
  • 9.3.1 Company Overview
  • 9.3.2 Company Revenue
  • 9.3.3 Products
  • 9.3.4 Recent Developments
• 9.4. Charles River Laboratories
  • 9.4.1 Company Overview
  • 9.4.2 Company Revenue
  • 9.4.3 Products
  • 9.4.4 Recent Developments
• 9.5. Syneos Health
  • 9.5.1 Company Overview
  • 9.5.2 Company Revenue
  • 9.5.3 Products
  • 9.5.4 Recent Developments
• 9.6. IQVIA Inc.
  • 9.6.1 Company Overview
  • 9.6.2 Company Revenue
  • 9.6.3 Products
  • 9.6.4 Recent Developments
• 9.7. GVK Biosciences Private Limited
  • 9.7.1 Company Overview
  • 9.7.2 Company Revenue
  • 9.7.3 Products
  • 9.7.4 Recent Developments
• 9.8. Laboratory Corporation Of America Holdings
  • 9.8.1 Company Overview
  • 9.8.2 Company Revenue
  • 9.8.3 Products
  • 9.8.4 Recent Developments
• 9.9. Parexel International Corporation
  • 9.9.1 Company Overview
  • 9.9.2 Company Revenue
  • 9.9.3 Products
  • 9.9.4 Recent Developments
• 9.10. Medidata Solutions Inc.
  • 9.10.1 Company Overview
  • 9.10.2 Company Revenue
  • 9.10.3 Products
  • 9.10.4 Recent Developments
• 9.11. Pharmaron GMBH
  • 9.11.1 Company Overview
  • 9.11.2 Company Revenue
  • 9.11.3 Products
  • 9.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Type (USD MN)
• Drug Discovery (Target Validation, Lead Identification, Lead Optimization) Market Sales By Geography (USD MN)
• Pre-clinical Market Sales By Geography (USD MN)
• Clinical (Phase I Trial Services, Phase II Trial Services, Phase III Trial Services, Phase IV Trial Services) Market Sales By Geography (USD MN)
• Analysis By Services (USD MN)
• Project Management/Clinical Supply Management Market Sales By Geography (USD MN)
• Data Management Market Sales By Geography (USD MN)
• Regulatory/Medical Affairs Market Sales By Geography (USD MN)
• Medical Writing Market Sales By Geography (USD MN)
• Clinical Monitoring Market Sales By Geography (USD MN)
• Quality Management/ Assurance Market Sales By Geography (USD MN)
• Bio-statistics Market Sales By Geography (USD MN)
• Investigator Payments Market Sales By Geography (USD MN)
• Laboratory Market Sales By Geography (USD MN)
• Patient And Site Recruitment Market Sales By Geography (USD MN)
• Technology Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Healthcare Contract Research Outsourcing Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Healthcare Contract Research Outsourcing Report
• Market Research Process
• Market Research Methodology
• Global Healthcare Contract Research Outsourcing Market Size, By Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Type
• Market Attractiveness Analysis By Services
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Type (USD MN)
• Drug Discovery (Target Validation, Lead Identification, Lead Optimization) Market Sales By Geography (USD MN)
• Pre-clinical Market Sales By Geography (USD MN)
• Clinical (Phase I Trial Services, Phase II Trial Services, Phase III Trial Services, Phase IV Trial Services) Market Sales By Geography (USD MN)
• Global Market Analysis By Services (USD MN)
• Project Management/Clinical Supply Management Market Sales By Geography (USD MN)
• Data Management Market Sales By Geography (USD MN)
• Regulatory/Medical Affairs Market Sales By Geography (USD MN)
• Medical Writing Market Sales By Geography (USD MN)
• Clinical Monitoring Market Sales By Geography (USD MN)
• Quality Management/ Assurance Market Sales By Geography (USD MN)
• Bio-statistics Market Sales By Geography (USD MN)
• Investigator Payments Market Sales By Geography (USD MN)
• Laboratory Market Sales By Geography (USD MN)
• Patient And Site Recruitment Market Sales By Geography (USD MN)
• Technology Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.